The UK government has got cold feet over plans to buy a million doses of AstraZeneca’s antibody treatment for coronavirus, according to a press report.
Novavax has finally provided some clarity about when its long-awaited COVID-19 vaccine will be ready, saying regulatory filings in the US, UK and Europe are due in the third quarter.
Shares in COVID-19 vaccine manufacturers have taken a hit after the US signalled its support for waiving patents on them, a move aimed to boost global supplies of the life-saving shots.